Hints and tips:
Related Special Reports
...Legal & General Investment Management, a top-10 shareholder in AstraZeneca, told the FT that it had decided to back the new remuneration policy....
...AstraZeneca said that “the new policy reflects the need to be competitive in the global market for talent and our compensation is structured to reward performance”....
...A new deal between drugmakers and the health service was agreed in November....
...AstraZeneca said: “The new policy reflects the need to be competitive in the global market for talent and our compensation is structured to reward performance.”...
...The Department of Health and Social Care has pledged to spend £2.3bn a year to expand mental health services in England by spring 2024....
...Research by the Centre for Policy Research, a New Delhi think-tank, shows spending on education, health and other areas has fallen proportionally....
...He had a chronic mental health condition, suffering from depression and anxiety, and had on occasion taken extended leave because of his mental health, according to the ruling....
...While it has several approved drugs that are antibody drug conjugates — a new, targeted form of chemotherapy — it has not developed radioconjugates, also known as radioligands....
...“The new policy reflects the need to be competitive in the global market for talent and our compensation is structured to reward performance,” the company said....
...But now, a new generation are embracing V-necks as their own....
...He sold off assets in non-core areas to invest heavily in research and development, plus fund acquisitions. There were setbacks, including criticism over its accounting practices....
...The group said it was affected by costs associated with the launch of new drugs including asthma medicine Airsupra. AstraZeneca beat expectations on sales, however....
...The writer is chair of AstraZeneca The AGM season is in full swing, and with it comes the usual set of controversies around remuneration....
...Shares edged 3 per cent higher to £104 by Monday afternoon following the news....
...Patients with terminal breast cancer in England will be denied access to a new treatment that has already been approved in Scotland, after a public health body said the drug did not provide value for money...
...US-based hedge fund Shah Capital wrote to the Novavax board on Monday to push for the instalment of two new independent board directors....
...Analysis by the Financial Times in February found that England needs as many as 500,000 new homes a year to keep pace with the rising population, well above the official target of 300,000 and the 234,400...
...Since then, the size of the Treasury basis trade — using hedge fund Treasury shorts as a proxy — has increased from about $650bn to a new record high of $800bn....
...For now, Tristram Hunt remains confident that the V&A can raise the funds to keep the “Deposition” in Britain....
...Ill health swells the welfare bill and is the prime reason why 2.83mn working-age Britons are economically inactive....
...The V&A’s new show, Tropical Modernism, revolves around this odd confluence....
...The most famous chess match of all time Bobby Fischer v Boris Spassky in 1972, still casts its echoes....
...The new deal will add a mid-stage drug to its new vaccine division, the creation of which was first reported by the Financial Times in 2021, for the first time....
...health treatments and clinics, according to three people familiar with discussions....
...The Church of England has been urged to set aside £1bn for a slavery reparations fund, in a report published by an independent oversight group....
International Edition